Searched for
AVENUE THERAPEUTIC
What if chronic nerve pain isn’t just something to block, but something to fix at the cellular level? New study reveals potential way to “recharge” nerve cells to relieve long-term painScientists are exploring a new way to treat chronic nerve pain by focusing on mitochondria, the energy-producing parts of cells. Researcher...
Stocks in news: YES Bank, Godrej Consumer, Kotak Bank, IDBI Bank, DMartShares of Godrej Consumer, Lupin, Indian Bank, and Marico will be in focus today as the companies will announce their quarterly results.
New Organic Co-crystal systems developed at IIT-GuwahatiA breakthrough in this evolving field has been documented through collaborative research, led by Prof Parameswar K Iyer of IIT Guwahati and...
8 stocks surge above 200 SMA: Cipla, Avenue Supermart, and Sun TV lead the rallySeveral stocks including Restaurant Brands Asia, Sun TV Network, Avenue Supermarts, Quess Corp, Cipla, Rain Industries, Affle (India), and ...
Cipla unit gets notice from US firm for termination of acquisition deal"Since the second stage closing could not be completed as per the agreed timelines, in the terms of the SPMA, InvaGen has received a notice...
Early antiviral response in nose may determine severity of COVID-19: StudyResearchers from Massachusetts Institute of Technology (MIT) and Harvard University in the US analysed whether the path towards severe dise...
Dr Reddy's inks licensing pact with Eli Lilly for COVID-19 treatment drugThe Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...
White House considering supporting India, S Africa move at WTO on COVID vaccines: ReportSuch a positive consideration by the Joe Biden administration comes after more than 60 lawmakers, mostly progressives, and a large number o...
Avenue Therapeutics gets regulatory update for intravenous tramadol, says CiplaIn October this year, Avenue Therapeutics Inc had received a complete response letter (CRL) from the USFDA which stated that the regulator ...
New Age diplomacy: Indian envoys & their counterparts brainstorm on digital platformOrganised by ‘Foundation for Public Awareness and Policy’, the main speakers of each dialogue were India's ambassadors/High Commissioner to...
PM Modi, Netanyahu vow to strengthen cooperation in dealing with coronavirus"Both the leaders agreed to increase cooperation in dealing with the coronavirus pandemic and also to expand cooperation in other areas," a...
Looking ahead: A class of antibiotics may help treat common form of dementiaFrontotemporal dementia, the most common type of the syndrome, begins between ages 40 and 65.
Beyond the canvas: Hotels, restaurants, hospitals are the new easel for Bengaluru artistsCollaboration with hotels is a great way for struggling or new artists to grab eyeballs.
India Inc's Jan-Nov M&A deal tally at $82 billion: ReportIn November 2017, there were 39 deals worth USD 3.2 billion.
Avenue Therapeutics buy will allow Cipla to enter specialty hospital business in US: Kedar UpadhyeWe are happy with the acceleration of the US pipeline, says Cipla’s Global CFO.
Cipla's subsidiary to acquire US-based Avenue Therapeutics for $ 215 millionAt the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the...
Revealed: Here's why we fall asleep when boredDo you experience an inescapable desire to sleep in boring situations?
India launches flagship program to boost biopharma productionThe ministry, which has received a loan of $125 million (over Rs 800 crore) from the World Bank for its “Innovate in India” (i3) program, h...
Zydus Cadila acquires US-based Sentynl Therapeutics"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...
- Odour receptors found in human lung tissue
London, Nov 4 (IANS) It was always thought that the sole bodily function of olfactory receptors was to smell and they could only be found i...